Globalization

Tigermed Envy? WuXi may be eyeing a launch on Shenzhen exchange

Tigermed Envy? WuXi may be eyeing a launch on Shenzhen exchange

By Zachary Brennan

With WuXi pushing full steam ahead in its bid to go private, one expert says that the company may be envious of a competing CRO -- Hangzhou Tigermed, which is smaller than WuXi but valued at a higher price on the Shenzhen stock exchange.

Follow us

Products

View more

Webinars